The system was called CREMONI II – Cardio REspiratoric MONITOR.
The special feature of CREMONI II was partly due to the fact that CREMONI II required for the first time only four adhesive electrodes to register a full-fledged 12-channel ECG from the human body surface, which required at least 10 electrodes beforehand.
After CREMONI II in 2002, exactly 10 years later, in 2012, the CARDIO Body Controle Telemetry System was presented for the first time.
The new concept of the ii-CBC Telemetry
(smartly individual Cardio Body Controle Telemetry).
The ii-CBC system represents the logical evolution of CREMONI II. The ii-CBC system is based on the analysis results of thousands of registered ECGs in patients with coronary angiographically verified circulatory disorders of the heart.
In the case of the ii-CBC system, in addition to the ECG, the blood pressure, blood sugar and weight data are forwarded via the mobile phone to a central office.
For the first time, every patient can compile his or her own customized monitoring system. Currently the telemetry systems are available for ECG, blood pressure (upper arm and lower arm), blood sugar and weight (balance).
The ii-CBC Telemetry System is thus currently the world’s first and only system with individual sensors in a matching analysis concept. For the first time, this completely new concept allows individual, intelligent assessment of pathological changes in comparison with the individual previous findings by means of measuring sensors individually adapted to the patient and his illnesses.
The procedure is for this reason called ii-CBC telemetry (smart individual cardio body control telemetry).
From the ECG conclusions are drawn about circulatory disorders, heart attack old or fresh, myocarditis, Herzrhytmusstoerugen and much more.
By comparing the current ECG data with an individual reference ECG, the results are graphically displayed in a body cake (heart rate, blood pressure, weight, blood sugar and cholesterol) and a cardio cake (HF, variability, R amplitude, ST slope, ST – Level, T-amplitude, T-wave Time to Peak, TU-Area).
In conjunction with the transmitted blood pressure and weight data in conjunction with the blood sugar, the system determines the cause of pathological changes with the greatest accuracy.
The one-hand program (“App”) allows direct one-hand operation with the aim to send the reference and current ECGs as well as other data on request directly as a PDF by e-mail or directly as a fax to the desired addressee (doctor) ,
For the first time, the system enables a direct intraindividual visualization of pathological biosignals.
SMS info of the patient
The system concept includes in the first stage the telemetry ECG, as well as a measuring system for blood pressure, blood sugar and the balance.
All systems can send the data via mobile phone to the central evaluation via “blue tooth”.
If pathological parameters have been determined (“alarm limits” previously specified), the customer will be sent an SMS with a code number.
The code number, after being forwarded by the alarmed customer, allows every doctor (if forwarded by the patient) to view all patient data via the NOWYMED II-CBC Cardio Body Controle Telemetry page on the Internet immediately for 2 hours.
In addition to the SMS, the data (pre-ECG and current ECG and / or possibly abnormal blood pressure changes) to the patient (and possibly specified by the patient competent medical specialists) as an email (PDF format) and / or fax delivered and also the doctors automated informed by SMS (only on request of the patient, previously selected doctors).
The complete telemetry system of the company Nowymed (ii-CBC) is available since mid-2013 in selected pharmacies, a measuring system for ECG, blood pressure (upper arm, forearm), blood sugar and weight (Libra).
The BMS stents show a more than 50% narrowing of the coronary artery over a period of 6 months in only about 15% of the patients (about every seventh patient). In the vast majority of patients (6 out of 7 patients), the vessel remains open throughout life after implantation of a BMS stent; special medication is required only for 4 weeks following stenting to prevent closure of the stent.
If narrowed, the narrowed stent may remain. In the stent, the “overgrown” tissue is crushed by a high pressure balloon (PTCA). Thereafter, the vessel remains permanently open in more than 50% of cases.
In addition to conventional stents, the most modern coated stents are used which have no re-constriction, so remain open for life.
The coated stents are also primarily metal stents, which, however, are additionally coated in the factory with a plastic polymer after production. This polymer is impregnated with a drug which, after implantation of the stent into the coronary artery, releases the coronary artery remedy over a period of several weeks (“eluting”). The coated stents are therefore also called DES (“drug eluting stents”) in contrast to the pure metal stents (BMS).
After implantation of a DES (“drug-eluting stent”), a special medication for 18 months after stenting is absolutely necessary to prevent the sudden (“acute”) occlusion of the stent. The long period (1.5 years) of pharmacological inhibition of platelet aggregation (platelet aggregation inhibition) in DES is necessary because the drug coating of the stent does not grow a “thin cuticle” (neointima) over the stent for a long time. The polymer and the metal of which the stent consist are therefore always in “direct” blood contact with the increased risk of sudden occlusion of the coronary vessel by the activated platelets in the absence of thrombocyte aggregation inhibition before neointima formation.
Incidentally, the most modern DES (drug eluting stents) not only absorbs the medication, it also resorbs the polymer for coating so that only the “pure” (bare metal stent) stent remains permanently in the vessel.
The Cardiac Cath Lab Doerr has a 24-hour readiness under the direction of Dr. Ing. Doerr and the skilled interventional cardiologists.
The cardiac catheterization laboratory is affiliated with a state-of-the-art internal cardiological intensive care unit.
The medical team of the internal department alone currently consists of 20 doctors, so that around the clock optimal aftercare of cardiac catheterization patients is guaranteed.
For vascular diagnostics (vascular diagnostics) especially state-of-the-art ultrasound examination sound heads are available for the vessels of the brain (transcranial Doppler), the carotid Doppler, the renal arteries (renal Doppler), the leg arteries and the leg veins (Beindoppler).
For specific questions, further non-invasive procedures are available for advanced cardiac diagnostics:
Long-term ECG with spectral analysis in frequency domain, frequency variability analysis event recorder Long-term blood pressure Continuous beat-to-beat blood pressure, baroreceptor analysis Impedance cardiography system (IKG, optoplethysmographic duplex IKG) Spiroergometry (cardiopulmonary performance recording) with training planning Treadmill ergometry with treadmill ergometer and lactate measurement if necessary Apex cardiography, cardiocymography and goniography ECG (vector ECG) Lung function analysis with bronchial resistance determination If the cardiological diagnosis is the indication for cardiac catheterization, the state-of-the-art cardiac catheterization laboratory Doerr directly opposite the doctor’s office in the Nardini Klinikum Zweibrücken with 24 hour standby available.
In the case of Dr. Doerr developed telemetry system II-CBC, in addition to the ECG and the data of blood pressure, blood sugar and weight via the mobile phone to a central office.
Every patient can for the first time put together an individual monitoring system adapted to his illnesses. Currently the telemetry systems are available for ECG, blood pressure (upper arm and forearm), blood glucose and weight (balance).
Dr. In the years 1996 to 2017, Doerr performed more than 16,000 cardiac catheter examinations at the Homburg, Pirmasens and Zweibrücken sites, with nearly 10,000 stent implantations and PTCAs (balloon dilatations). Since 2004, about 5,000 cardiac catheter examinations have been performed in Zweibrücken.
Dr. Doerr was born in Zweibrücken in 1962. A city that has not only roses and steeds to offer, but also brought many inventors to light.
In 1981, Thomas Doerr graduated from the natural science Helmholtz high school and then devoted himself entirely to medicine. His doctorate and dissertation took place at the founder of nuclear medicine, the famous physicist and physician Prof. dr. rer. nat. Dr. med. Erich Oberhausen.
Afterwards his professional career led him to Prof. Dr. med. Wolfgang Trautwein, the inventor of the Voltage Clamp at heart 1963 in Heidelberg and successor of Helmholtz at the Department of Physiology in Heidelberg.
Together with Wolfgang Trautwein, Ralf Denger and Anke Doerr, the scientific breakthrough came in 1988, the first year of his scientific activity at the age of 25:
The “Action Potential Clamp”, a now world-wide approved and internationally recognized method for the investigation of the electrical processes in heart cells, the basis for the understanding of the electrocardiogram (ECG).
In the last 30 years Dr. Thomas Doerr Five Great, Revolutionary Ideas:
Action Potential Clamp (1988) (Examination of the function of cardiac cells under physiological conditions) Duplex Impedance Cardiography with Optoplethysmography 1993, European patent, the best pacemaker optimization Intraoronary ECG and intracoronary pacing in rotablation and PTCA, 1997 The intraindividual 4 electrodes ECG, presentation Cremoni Medica 2001 Cardiosecure active and Cardiosecur Pro 2009, 4 International “Awards” ….. These ideas count as medical milestones in cardiology and prevention! Dr. Thomas Doerr is an excellent internist, cardiologist, intensive care and flight medicine. Especially in aviation medicine, his practical experience as a pilot for private aircraft, helicopters, gyroplane trikes and motor gliders helps him.
In his many years as a physician, he has performed several hundred thousand ultrasound examinations on the heart and blood vessels, placed 16,000 cardiac catheters and 10,000 interventions, PTCAs and stents.
In addition to his practical work, he has published more than 100 publications, has 3 patents in the field of ECG, impedance cardiography and photoplethysmography (PPG) and created 5 educational films on the functions of the heart and vessels, as well as on the function of individual heart cells (TIB, Google).
Dr. Doerr is not a man of stasis. For him, research is an unlimited field of play in which there is always something to discover and something to improve.
True to his motto: “Prevention is just one word, but health is everything for our lives! Prevention is just a word, but health is everything for our life!